Nurami Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $30M

  • Investors
  • 15

Nurami General Information

Description

Developer of biomaterials and nanofiber-based matrix designed to improve patient outcomes in various surgical procedures. The company's matrices combine porous scaffold for tissue regeneration enhancement with a novel temperature-sensitive sealant to prevent the entry of pathogens and CSF leaks, enabling surgeons to answer the unmet needs of their patients.

Contact Information

Website
www.nurami-medical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Vertical(s)
Nanotechnology, HealthTech, Life Sciences
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972

Nurami Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 03-Mar-2025 $30M Completed Generating Revenue
14. Grant 16-Jul-2024 Completed Generating Revenue
13. Later Stage VC 16-Jul-2024 Completed Generating Revenue
12. Accelerator/Incubator 03-Jun-2024 Completed Generating Revenue
11. Grant 01-Jan-2023 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Grant 01-Jan-2021 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Later Stage VC (Series B) 02-Nov-2020 $6M $9.7M Completed Generating Revenue
6. Grant 01-Jan-2020 $1.2M $3.74M Completed Generating Revenue
To view Nurami’s complete valuation and funding history, request access »

Nurami Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred A
Ordinary A
To view Nurami’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Nurami Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomaterials and nanofiber-based matrix designed to improve patient outcomes in various surgical procedures
Surgical Devices
Haifa, Israel
22 As of 2025

Paramus, NJ
 

Portage, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nurami Competitors (3)

One of Nurami’s 3 competitors is Regenity, a Private Equity-Backed company based in Paramus, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenity Private Equity-Backed Paramus, NJ
Stryker Formerly VC-backed Portage, MI
Integra Lifesciences Corporation Princeton, NJ
You’re viewing 3 of 3 competitors. Get the full list »

Nurami Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Nurami Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220273842-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
EP-4003437-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
CA-3144451-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
AU-2020316756-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
EP-4003437-A4 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 A61L24/0015
To view Nurami’s complete patent history, request access »

Nurami Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurami Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Venture Capital Minority
Iron Nation Venture Capital Minority
MedTech Innovator Accelerator/Incubator
Almeda Ventures Venture Capital Minority
GlenRock Israel Growth/Expansion Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Nurami FAQs

  • When was Nurami founded?

    Nurami was founded in 2014.

  • Where is Nurami headquartered?

    Nurami is headquartered in Haifa, Israel.

  • What is the size of Nurami?

    Nurami has 22 total employees.

  • What industry is Nurami in?

    Nurami’s primary industry is Surgical Devices.

  • Is Nurami a private or public company?

    Nurami is a Private company.

  • What is Nurami’s current revenue?

    The current revenue for Nurami is .

  • How much funding has Nurami raised over time?

    Nurami has raised $39.7M.

  • Who are Nurami’s investors?

    European Innovation Council, Iron Nation, MedTech Innovator, Almeda Ventures, and GlenRock Israel are 5 of 15 investors who have invested in Nurami.

  • Who are Nurami’s competitors?

    Regenity, Stryker, and Integra Lifesciences are competitors of Nurami.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »